SUPN
SupernusBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
SUPN vs peer average
65/100
SUPN vs. peer average (B vs. C)
Grade spread
A 2 · B 1 · C 4 · D 4
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
ACAD is the first available peer comparator.
CNS-focused specialty pharma with marketed neuropsychiatric products and similar commercialization dynamics.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
SUPN
Supernus
ACAD
ACADIA
Grade
B
A
Momentum
25
75
Value
60
62
Sentiment
75
50
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs ACAD
SUPN / ACAD
Grade Position
In line
SUPN vs. peer average (B vs. C)
65/100
Momentum
25
ACADValue
60
ACADSentiment
75
SUPNRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs SUPN
ACAD is the first peer returned for this comparison set.

